---
ver: rpa2
title: 'Multimodal Data Integration for Oncology in the Era of Deep Neural Networks:
  A Review'
arxiv_id: '2303.06471'
source_url: https://arxiv.org/abs/2303.06471
tags:
- data
- learning
- graph
- multimodal
- cancer
- transformers
- self-attention
- retrieval-augmented-generation
- instruction-tuning
- parameter-efficient-finetuning
- mixture-of-experts
- chain-of-thought
core_contribution: This survey comprehensively analyzes deep neural network-based
  multimodal data fusion approaches for oncology, focusing on Graph Neural Networks
  (GNNs) and Transformers. The paper provides an in-depth taxonomy of multimodal learning,
  covering data preprocessing, feature extraction, fusion techniques (early, intermediate,
  late), primary learners, and final classifiers.
---

# Multimodal Data Integration for Oncology in the Era of Deep Neural Networks: A Review

## Quick Facts
- arXiv ID: 2303.06471
- Source URL: https://arxiv.org/abs/2303.06471
- Reference count: 40
- This survey comprehensively analyzes deep neural network-based multimodal data fusion approaches for oncology, focusing on Graph Neural Networks (GNNs) and Transformers.

## Executive Summary
This comprehensive review examines deep learning approaches for integrating multimodal oncology data, with particular emphasis on Graph Neural Networks (GNNs) and Transformers. The paper provides a systematic taxonomy covering data preprocessing, feature extraction, fusion techniques, and learning architectures. It addresses the growing need for multimodal integration in cancer diagnosis, prognosis, and treatment planning by synthesizing current state-of-the-art methods and identifying key challenges in the field.

The review highlights the potential of GNNs and Transformers to capture complex relationships across heterogeneous oncology data modalities including pathology, radiology, and molecular data. By analyzing both unimodal and multimodal approaches, the authors establish a framework for understanding how deep learning can address the unique challenges of cancer data integration while identifying critical areas for future research and development.

## Method Summary
The review synthesizes current approaches for multimodal oncology data integration using deep neural networks. It systematically examines data preprocessing techniques, feature extraction methods for different modalities, and fusion strategies including early, intermediate, and late fusion. The authors analyze Graph Neural Networks and Transformers as primary learning frameworks, evaluating their applicability to various oncology data types and integration challenges.

The methodology involves a comprehensive literature review of existing deep learning approaches, with a focus on GNNs and Transformers for multimodal learning. The review identifies publicly available oncology datasets and discusses implementation considerations for different fusion strategies. Key aspects include handling missing data, addressing modality imbalance, and ensuring model interpretability in clinical settings.

## Key Results
- Provides a comprehensive taxonomy of multimodal learning approaches specifically for oncology applications
- Identifies key challenges in multimodal oncology learning including data availability, alignment, missing modalities, and explainability
- Presents both unimodal and multimodal integration approaches across pathology, radiology, and molecular data modalities
- Discusses future directions for developing scalable, interpretable, and generalizable deep learning frameworks

## Why This Works (Mechanism)

### Mechanism 1
- Claim: Transformers can unify heterogeneous oncology data modalities by treating each token (or embedding) as a node in a fully connected graph.
- Mechanism: The self-attention mechanism in Transformers allows each modality to attend to others, capturing cross-modal dependencies without requiring explicit alignment.
- Core assumption: All modalities can be tokenized into comparable vector representations that preserve modality-specific semantics.
- Evidence anchors:
  - [abstract] Recent deep learning frameworks such as Graph Neural Networks (GNNs) and Transformers have shown remarkable success in multimodal learning.
  - [section] Transformers can handle sequential data and learn long-range dependencies, making them well-suited for tasks such as language translation and language modeling. Unlike Recurrent Neural Networks (RNNs) and CNNs, Transformers use self-attention operations to weigh the importance of different input tokens (or embeddings) at each time step.
  - [corpus] Weak - no direct transformer-based oncology studies in neighbors.
- Break condition: Tokenization fails to preserve modality-specific semantics or leads to information loss.

### Mechanism 2
- Claim: GNNs can capture the relational connectivity inherent in cancer data across scales by modeling data as graphs.
- Mechanism: GNNs aggregate information from neighboring nodes through message passing, allowing them to learn high-order structural information and denoise features.
- Core assumption: Cancer data has meaningful relational structures that can be represented as graphs.
- Evidence anchors:
  - [abstract] Recent deep learning frameworks such as Graph Neural Networks (GNNs) have shown remarkable success in multimodal learning.
  - [section] GNNs are a type of neural network specifically designed to process data represented as a graph [87], which makes them well-suited for analyzing complex and connected data, such as multimodal oncology data.
  - [corpus] Weak - only one neighbor paper mentions GNNs briefly without implementation details.
- Break condition: Over-smoothing occurs, causing node representations to become too similar and lose discriminative power.

### Mechanism 3
- Claim: Multimodal fusion at different stages (early, intermediate, late) provides complementary benefits for integrating oncology data.
- Mechanism: Early fusion combines features before model training, intermediate fusion trains separate models per modality then combines outputs, and late fusion combines decisions after individual model predictions.
- Core assumption: Different fusion strategies are appropriate for different types of modality relationships and data characteristics.
- Evidence anchors:
  - [section] Data fusion can be done using early, late, or intermediate fusion. Detailed discussion on these fusion stages is presented in Section 2.3.
  - [section] Early fusion is the simplest way to combine data from multiple modalities. The data from different modalities are concatenated to a single input before feeding it to the model.
  - [corpus] Weak - no corpus papers specifically address multimodal fusion strategies in oncology.
- Break condition: Inappropriate fusion strategy chosen for modality characteristics leads to poor performance.

## Foundational Learning

- Concept: Graph representation learning
  - Why needed here: Oncology data often has relational structures (cell interactions, molecular pathways) that graphs naturally represent
  - Quick check question: What are the key differences between homogeneous and heterogeneous graphs in representing oncology data?

- Concept: Attention mechanisms in Transformers
  - Why needed here: Attention allows the model to weigh the importance of different modalities dynamically during processing
  - Quick check question: How does self-attention differ from cross-attention in multimodal Transformer architectures?

- Concept: Data modality characteristics and tokenization
  - Why needed here: Different oncology data types (images, sequences, clinical records) require different tokenization strategies for effective multimodal learning
  - Quick check question: What tokenization approaches would be most appropriate for pathology images versus genomic sequences?

## Architecture Onboarding

- Component map: Data preprocessing -> Feature extraction -> Fusion -> Primary learner -> Classifier
- Critical path: Data preprocessing → Feature extraction → Fusion → Primary learner → Classifier
- Design tradeoffs:
  - Early fusion: Simpler but assumes modalities are equally important
  - Late fusion: Preserves modality-specific features but may miss interactions
  - Hybrid approaches: More complex but can capture both modality-specific and cross-modal information
- Failure signatures:
  - Over-smoothing in GNNs: Node representations become too similar
  - Modality collapse: Model relies too heavily on one modality
  - Missing data issues: Model cannot handle incomplete modality sets
- First 3 experiments:
  1. Implement early fusion baseline: Concatenate features from pathology images (CNN-extracted) and genomic data (GNN-extracted) before classification
  2. Implement late fusion baseline: Train separate models on each modality then combine predictions using weighted voting
  3. Implement cross-attention Transformer: Use self-attention to capture within-modality relationships and cross-attention for between-modality interactions

## Open Questions the Paper Calls Out

### Open Question 1
- Question: What specific mechanisms can be implemented to improve the generalization of multimodal models across different cancer types and sites?
- Basis in paper: [inferred] The paper mentions that developing models that generalize across different cancer sites is challenging due to unique characteristics and challenges of each site.
- Why unresolved: Current models often underperform when applied to different cancer types due to inter-cancer and inter-site variations. There is a need for mechanisms to improve the universality of ML models.
- What evidence would resolve it: Empirical studies demonstrating improved model performance across multiple cancer types using proposed generalization mechanisms.

### Open Question 2
- Question: How can the explainability and trustworthiness of multimodal GNNs and Transformers be improved in oncology applications?
- Basis in paper: [explicit] The paper highlights the challenge of explaining decisions made by multimodal models and establishing their trustworthiness, especially given the complexity of combining information from multiple modalities.
- Why unresolved: Existing explainability methods are insufficient for the complexity of multimodal models, and there is a lack of robust techniques to ensure trustworthiness in clinical settings.
- What evidence would resolve it: Development and validation of new explainability techniques specifically designed for multimodal models, along with clinical trials demonstrating improved trust and reliability.

### Open Question 3
- Question: What strategies can be employed to effectively handle missing data samples and modalities in multimodal oncology learning?
- Basis in paper: [explicit] The paper identifies the challenge of missing data samples and modalities, noting that most existing DL models cannot process "missing information."
- Why unresolved: The requirement for complete data constrains the already limited size of oncology datasets, and current approaches for handling missing data are insufficient.
- What evidence would resolve it: Comparative studies showing improved model performance when using novel strategies for handling missing data in multimodal settings.

## Limitations

- Limited discussion of temporal dynamics in longitudinal multimodal data
- Insufficient coverage of privacy and ethical considerations in multimodal data integration
- The review focuses primarily on technical aspects without addressing clinical validation requirements

## Confidence

- Confidence is Medium for the proposed mechanisms as most claims are supported by general DL literature rather than oncology-specific studies.
- Major uncertainties include scalability to real-world clinical settings, computational requirements for large-scale datasets, and generalizability across different cancer types.

## Next Checks

1. **Implementation validation**: Implement a simple cross-attention Transformer architecture on a benchmark multimodal oncology dataset (e.g., TCGA) to verify the theoretical claims about modality interactions.

2. **Scalability testing**: Evaluate the proposed GNN-based approach on progressively larger oncology graphs to identify computational bottlenecks and assess real-world feasibility.

3. **Clinical utility assessment**: Design a study to compare the diagnostic performance of multimodal approaches against clinical experts using the same patient cohorts and clinically relevant metrics.